- Zacks•11 days ago
TrovaGene (TROV) recently inked a partnership with the USC Norris Comprehensive Cancer Center, which aims at building a standardized framework for the use of the Trovera system.
- Zacks•17 days ago
TrovaGene Inc. (TROV) is collaborating with the University of Michigan to conduct a multi-phased research program using Trovera KRAS ctDNA liquid biopsy test.
After hours: 5.040.00 (0.00%) as of 4:44 PM EDT
|Bid||5.01 x 500|
|Ask||5.28 x 1000|
|52wk Range||2.85 - 8.80|
|Day's Range||5.02 - 5.27|
|Avg Vol (3m)||451,238|
As of 4:00 PM EDT. Market closed.